FDA Inspection
Janssen Pharmaceuticals, Inc.Janssen Pharmaceuticals, Inc. – FDA Inspection, Jan 24, 2025
Record Details
This FDA Inspection record concerns Janssen Pharmaceuticals, Inc., with an inspection on January 24, 2025, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · 08273c5d-35aa-4f0a-b884-76d3359515cc
Inspection Facts
- Inspection number
- 1259762
- FDA center
- Human Drugs
Other FDA inspections of Janssen Pharmaceuticals, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 14, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2009 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Janssen Pharmaceuticals, Inc.
- FDA Inspection 1025904 - 2017-07-14
- FDA Inspection 867768 - 2014-02-20
- FDA Inspection 717213 - 2011-02-18
- FDA Inspection 574811 - 2009-03-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.